The Parsortix® PC1 Clinical System Small but powerful. Simple but versatile. The first FDA cleared medical device for the capture and harvest of circulating tumor cells (CTCs) from metastatic breast cancer patient blood for subsequent, user-validated analysis. Visit Booth 929 to discover the potential of CTCs with the power of Parsortix® technology. www.angleplc.comhttps://angleplc.com/parsortix-pc1-clinical-system/